BIT Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-73,990
| Closed | -$10.2M | – | 90 |
|
|
2024
Q4 | $10.2M | Buy |
73,990
+5,569
| +8% | +$767K | 0.81% | 19 |
|
|
2024
Q3 | $10.2M | Sell |
68,421
-36,217
| -35% | -$5.41M | 0.95% | 21 |
|
|
2024
Q2 | $14.3M | Sell |
104,638
-5,000
| -5% | -$682K | 1.12% | 19 |
|
|
2024
Q1 | $16.6M | Buy |
109,638
+48,108
| +78% | +$7.27M | 1.23% | 16 |
|
|
2023
Q4 | $7.75M | Buy |
61,530
+52,407
| +574% | +$6.6M | 0.76% | 26 |
|
|
2023
Q3 | $854K | Hold |
9,123
| – | – | 0.1% | 54 |
|
|
2023
Q2 | $814K | Buy |
9,123
+1,700
| +23% | +$152K | 0.08% | 67 |
|
|
2023
Q1 | $796K | Buy |
7,423
+445
| +6% | +$47.7K | 0.12% | 62 |
|
|
2022
Q4 | $852K | Buy |
6,978
+2,249
| +48% | +$275K | 0.17% | 41 |
|
|
2022
Q3 | $488K | Buy |
4,729
+3,929
| +491% | +$406K | 0.09% | 62 |
|
|
2022
Q2 | $74.4K | Hold |
800
| – | – | 0.01% | 94 |
|
|
2022
Q1 | $93.9K | Buy |
+800
| New | +$93.9K | 0.01% | 97 |
|